In the latest close session, Merck (MRK) was down 2.15% at $126.78. This change lagged the S&P 500's 0.72% gain on the day. On the other hand, the Dow registered a gain of 0.3%, and the ...

German pharma giant Merck has inked a deal to acquire US life sciences company Bio-Techne for $11. 3 billion to expand its ...

Merck draws attention as healthcare strength, pharma activity, and defensive market rotation place large drugmakers back in ...

By Christy Santhosh, Padmanabhan Ananthan and Bhanvi Satija June 25 (Reuters) - German drugmaker Merck KGaA said on Thursday ...

RAHWAY, N.J. and FOSTER CITY, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: ...

Rahway-based pharma giant Merck finalized its $6.7 billion acquisition of Terns Pharmaceuticals. When the deal closed May 5, the California-headquartered oncology company became a wholly owned ...

Merck (MRK) closed the most recent trading day at $128.66, moving +2.56% from the previous trading session. The stock's ...

RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Orna Therapeutics, a biotechnology company pioneering a new investigational ...

Johnson & Johnson is a global leader in the pharmaceutical and medical device industries. Its key products include anti-inflammation drug Stelara, multiple myeloma and light chain ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that the companies ...